Can phosphatidylcholine (TGL Slim injectable) be administered on the same day as Anti-Tetanus Shot (ATS) and Tuberculosis Test (TT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Phosphatidylcholine (TGL Slim) Be Given the Same Day as Anti-Tetanus Shot (ATS) and Tuberculosis Test (TT)?

Yes, phosphatidylcholine injections can be administered on the same day as tetanus vaccination and tuberculin testing, as there are no documented contraindications or interactions between these interventions.

Rationale for Same-Day Administration

Tetanus Vaccination Compatibility

  • Tetanus vaccines can be given simultaneously with other vaccines and medical procedures when indicated, using separate syringes at different anatomic sites 1, 2.
  • The ACIP explicitly states that if two or more vaccines are indicated, they should be administered during the same visit, with each using a separate syringe at different anatomic sites 1, 2.
  • Inactivated vaccines (including tetanus toxoid) may be administered at any time before or after different inactivated vaccines or other medical procedures unless a specific contraindication exists 1.

Tuberculin Testing Compatibility

  • Tuberculin purified protein derivative (PPD) testing is a diagnostic skin test, not a vaccine, and does not interfere with other injectable medications administered at different sites 1.
  • The only documented concern with tuberculin testing relates to accidental administration errors where tetanus toxoid has been mistakenly given instead of PPD, which is a provider error issue, not a contraindication 1.

Phosphatidylcholine Safety Profile

  • Phosphatidylcholine injections are localized subcutaneous treatments that work through adipocyte necrosis and local inflammatory responses confined to the injection site 3, 4, 5.
  • The treatment does not affect systemic markers of inflammation, glucose metabolism, or lipid profiles 4.
  • Systemic side effects occur in only 3% of cases and are predominantly mild (diarrhea, nausea, dizziness), with no documented immunologic interactions 3.

Practical Administration Guidelines

Site Selection Strategy

  • Administer tetanus vaccine intramuscularly in the deltoid muscle (0.5 mL dose) 1, 2.
  • Place tuberculin test on the volar surface of the forearm (standard PPD placement).
  • Inject phosphatidylcholine subcutaneously at the intended treatment area (abdomen, thighs, periorbital region, etc.), which will be anatomically separate from the vaccine and test sites 3, 6.
  • Maintain at least one inch separation between any injections in the same general area 2.

Timing Considerations

  • No waiting period is required between these procedures when performed on the same day 1.
  • The 15-20 minute post-vaccination observation period recommended for syncope prevention applies to the tetanus vaccine, not the phosphatidylcholine injection 2.

Important Caveats

Patient Counseling

  • Inform patients that local reactions at each injection site are expected and independent:
    • Tetanus vaccine: possible soreness, redness, swelling at deltoid 1
    • Tuberculin test: induration develops over 48-72 hours at forearm site
    • Phosphatidylcholine: burning, erythema, swelling, tenderness at treatment site (described as mild in 57.6% of cases) 3

Documentation Requirements

  • Record all three procedures separately with specific anatomic sites documented to prevent confusion and ensure proper tuberculin test reading at 48-72 hours 1.

Contraindications to Monitor

  • The only scenario requiring caution would be a patient with a history of Arthus reaction to previous tetanus vaccination, which would contraindicate tetanus vaccine administration (but not affect phosphatidylcholine or tuberculin testing) 1.
  • Minor concurrent illness is not a contraindication to any of these procedures 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.